The Experience-Trajectory Framework: Substance-Specific Risk Stratification for Psychedelic Preparation and Aftercare Beyond Set and Setting

Elias Rubenstein

doi:10.36948/ijfmr.2026.v08i04.84804

The Experience-Trajectory Framework: Substance-Specific Risk Stratification for Psychedelic Preparation and Aftercare Beyond Set and Setting

Author(s)	Dr. Elias Rubenstein
Country	United States
Abstract	Set, setting, preparation, and integration are widely recognized as important dimensions of psychedelic experiences. However, these concepts often remain too general to specify how preparation, containment, and aftercare should differ across substances, routes of administration, acute duration, residual effects, bodily condition, and interaction exposure. This article proposes the Experience-Trajectory Framework for psychedelic preparation and aftercare. The framework focuses on psilocybin, LSD, mescaline, vaporized N,N-DMT, vaporized 5-MeO-DMT, and ayahuasca or oral DMT combined with monoamine oxidase inhibition. Its central claim is that preparation and aftercare should be stratified by two primary variables: the Experience-Trajectory Profile of the psychedelic state and the participant’s Baseline Risk State before exposure. Experience-Trajectory Profile refers to onset, peak phase, acute duration, residual effects, recovery window, and the earliest appropriate timing for interpretation or integration. Baseline Risk State refers to the participant’s acute physiological and pharmacological condition, including sleep, hydration, cardiovascular stability, gastrointestinal status, glucose stability, psychological stability, and interaction load. This article is a conceptual framework paper, not a clinical protocol or medication-discontinuation guide. It provides a stratification model that links substance-specific experience trajectories with baseline physiological and interaction states to derive containment intensity, aftercare timing, and post-acute meaning-regulation needs. By distinguishing compressed, medium-duration, long-duration, and MAO-mediated experience profiles, the framework clarifies why different psychedelic contexts require different screening, containment, stabilization, and follow-up procedures. It is intended as a research-oriented framework for conceptual clarification, safety documentation, retreat-safety evaluation, and future empirical refinement. The framework also offers a basis for future comparative research on preparation standards, retreat safety practices, and post-acute stabilization across different psychedelic contexts.
Keywords	psychedelics, experience trajectory, baseline risk state, interaction load, aftercare, DMT, 5-MeO-DMT, LSD , mescaline , MAOI, MDMA
Field	Medical / Pharmacy
Published In	Volume 8, Issue 4, July-August 2026
Published On	2026-07-31
DOI	https://doi.org/10.36948/ijfmr.2026.v08i04.84804

View / Download PDF File

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9687-828-838	editor@ijfmr.com

International Journal For Multidisciplinary Research

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

The Experience-Trajectory Framework: Substance-Specific Risk Stratification for Psychedelic Preparation and Aftercare Beyond Set and Setting

Share this